We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Recarbio was previously approved for treatment of complicated urinary tract infections and complicated intra-abdominal infections in patients with limited or no alternative treatment options. Read More
A Texas study of convalescent plasma as a treatment for critically ill COVID-19 patients found the blood-based treatment to be safe for severely infected patients. Read More
The Lancet and the New England Journal of Medicine (NEJM) yesterday retracted separate studies of two different COVID-19 treatments because of concerns over the underlying data provided by the same data analytics company, Surgisphere. Read More